Yuhan Corp. to market Nippon Shinyaku's prulifloxacin in Korea

Published: 2003-02-21 06:56:00
Updated: 2003-02-21 06:56:00
Yuhan Corp. announced on February 17 that it signed a licensing agreement with Japanese drug market Nippon Shinyaku for the long-term exclusive marketing of oral quinolone antibiotic prulifloxacin in Korea..

Yuhan Corp. said that prulifloxacin is an innovative drug as a prodrug type for the fi...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.